HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas.

Abstract
Frequency and distribution of 5-fluorodeoxyuridine (5-FdU) plus caffeine-induced fragile sites on chromosomes of peripheral blood lymphocytes (PBL) from 10 patients with cutaneous melanoma were studied in comparison with 10 PBL samples from normal donors of corresponding sex and age. The total number of breaks showed a significant difference among individuals in both groups, however, the average frequencies of 5-FdU plus caffeine-induced, as well as spontaneous damages in PBL from melanoma patients, were higher than those from healthy volunteers. The analysis of the breakpoint distribution showed a statistically significant increase in the expression of several fragile sites. The highest enhancement was observed at 1p32 and 1p22 sites (p less than 0.001). Earlier, the increase in the expression of 1p32 fragile sites was reported for neuroblastoma patients. We believe that enhanced expression of fragile sites in 1p may play a yet-unknown pathogenetic role in the development of some neuroectodermal tumors.
AuthorsO I Sokova, O P Kirichenko, A F Mukeria, L V Demidov, A N Chebotarev, B P Kopnin
JournalCancer genetics and cytogenetics (Cancer Genet Cytogenet) Vol. 58 Issue 1 Pg. 24-8 (Jan 1992) ISSN: 0165-4608 [Print] United States
PMID1530833 (Publication Type: Journal Article)
Chemical References
  • Floxuridine
  • Caffeine
Topics
  • Adult
  • Caffeine (pharmacology)
  • Cells, Cultured
  • Chromosome Fragile Sites
  • Chromosome Fragility
  • Chromosomes, Human, Pair 1
  • Female
  • Floxuridine (pharmacology)
  • Humans
  • Lymphocytes (drug effects, pathology)
  • Male
  • Melanoma (blood, genetics)
  • Middle Aged
  • Skin Neoplasms (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: